Loading…
Loading…
RMSL does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for RMSL and 80,000+ other tickers.
See exactly how RMSL's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for RMSL and 80,000+ other tickers.
REMSleep Holdings, Inc. is an enterprise globally focused on crafting and providing solutions for individuals afflicted with sleep apnea. Among its key offerings is the DeltaWave CPAP interface device, specifically engineered to aid in the treatment of patients suffering from this condition. The company caters to a broad spectrum of clients, including home healthcare providers, independent sleep clinics, direct consumers, medical practitioners, group medical organizations, hospitals, and various professional medical associations. Its corporate headquarters are situated in Tampa, Florida.
REMSleep Announces Strategic launch of the Deltawave™ CPAP Mask System BLACKSHEAR, GA / ACCESS Newswire / October 1, 2025 / RemSleep Holdings, Inc. (OTCID:RMSL) Remsleep, the developer of the FDA-Cleared Deltawave™ CPAP mask system gives shareholder update on progress and status of Deltawave™ launch. Remsleep has finalized contracts with independent sales reps covering the entire US.
Remsleep seeking Clinical Trials and Resellers for new arrival CPAP mask. CLEARWATER, FL / ACCESS Newswire / June 30, 2025 / Remsleep Holdings, Inc. (OTC Pink:RMSL) Sleep, Naturally - The Deltawave™ Experience.
CLEARWATER, FL / ACCESS Newswire / May 13, 2025 / REMSleep Holdings, Inc. (OTC PINK:RMSL) Enters into Formal Agreement with www.1800CPAP.com , a major DME distributor. The DeltaWave is now available nationwide.
CLEARWATER, Fla., Nov. 15, 2024 (GLOBE NEWSWIRE) -- REMSleep Holdings, Inc. (OTCQB: RMSL): To all stockholders, this is an update as to the status of the launch of the Deltawave product to the marketplace.
CLEARWATER, FL, Sept. 03, 2024 (GLOBE NEWSWIRE) -- REMSleep Holdings, Inc. (OTCQB: RMSL) announces that another utility patent for its Nasal Ventilation System has been allowed by the United States Patent and Trademark Office. REMSleep will file the necessary paperwork to pay for issuance and, thereafter, REMSleep should be awarded a patent in approximately 8 weeks. REMSleep will maintain a continuation application for adding any improvements and/or changes to the patent lineage.